Senzime AB (publ) (“Senzime” or the “Company”) announced on 24 August 2023 the board of directors’ resolution to carry out a directed share issue of approximately MSEK 56, at current market price. Chairman of the board, Adam Dahlberg, participated in the rights issue, which was subject to approval from the general meeting. Subscription of 1,137,500 shares has now been made and the directed share issue of approximately MSEK 56 is therefore fully subscribed.
The subscription of shares in the directed issue of shares to the Company’s chairman of the board, Adam Dahlberg, lasted until 21 September 2023 and has now concluded. The rights issue was fully subscribed, resulting in the Company raising approximately MSEK 5.1. The subscription price in the directed issue of shares was SEK 4.50 per share, which is the same subscription price as the issue of shares which was resolved and announced on 24 August 2023.
The directed issue of shares results in an increase in the number of shares in the Company by 1,137,500 shares from 98,985,114 to 100,122,614. The share capital of the Company increases by SEK 142,187.50, from SEK 12,373,139.25 to SEK 12,515,326.75. Consequently, the new issue of shares leads to a dilution of approximately 1.1% based on the total number of shares in the Company after the rights issue."
Advisers
In connection with the Share Issue, the Company has retained Zonda Partners as financial advisor and Advokatfirman Lindahl KB as legal adviser to the Company.